跳至主要内容
临床试验/NCT06398938
NCT06398938招募中不适用

EROS 3 Study Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy Brachytherapy in Terms of Overall Toxicity and Sexual Activity

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 个研究点 分布在 1 个国家目标入组 129 人开始时间: 2024年5月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
129
试验地点
1
主要终点
Acute and late gastrointestinal toxicity

研究概览

简要总结

To evaluate the degree of acute and long-term intestinal, urinary and vaginal toxicity, and the impact on sexual activity of an accelerated fractionation of high dose rate interventional radiotherapy (IRT-HDR) in patients with locally advanced cervical cancer (IB2 - VA, N+/-).

详细描述

Observational, monocentric and prospective study. All patients with locally advanced cervix cancer will be underwent to radiochemotherapy followed by accelerated interventional radiotherapy (brachytherapy). Fist endpoints wer severe acute and late gastrointestinal, and urinary toxicities and sexual activity.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age ≥18 years
  • Histological diagnosis of squamous carcinoma and/or adenocarcinoma of the uterine cervix
  • FIGO IB2 Stadium - IVA (staging 20018)
  • No contraindications to performing MRI of the pelvis
  • Informed consent

排除标准

  • Age <18 years
  • Previous cancer in the last 10 years
  • Previous radiation treatment in the region of interest
  • Presence of pathologies that contraindicate radiotherapy treatment (genetic syndromes of hyper-radiosensitivity, ulcerative colitis, diverticulitis in the acute phase, severe diverticulosis, chronic pelvic inflammation)
  • Presence of internal diseases that contraindicate chemotherapy or radio-chemotherapy treatment (severe liver disease, heart disease, renal failure, etc.)
  • Presence of distant metastases in sites other than the pelvic lymph nodes
  • Any significant medical condition that in the opinion of the investigator may interfere with the patient's optimal participation in the study

结局指标

主要结局

Acute and late gastrointestinal toxicity

时间窗: 6 months

Acute and late toxicities will evaluated with CTCAE scale to analyze the safety of accelerated interventional radiotherapy

Acute and late urinary toxicity

时间窗: 6 months

Acute and late urinary toxicities will evaluated with CTCAE scale to analyze the safety of accelerated interventional radiotherapy

Sexual activity

时间窗: 6 months

Sexual activity will evaluated with CTCAE scale to analyze the safety of accelerated interventional radiotherapy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation of Ultraaccelerated High Dose Rate... | 临床试验